Penumbra Inc (PEN) — SEC Filings
Penumbra Inc (PEN) — 26 SEC filings. Latest: 425 (May 7, 2026). Includes 8 8-K, 6 SC 13G/A, 5 10-Q.
View Penumbra Inc on SEC EDGAR
Overview
Penumbra Inc (PEN) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 5, 2025: Penumbra Inc. reported robust financial performance for the nine months ended September 30, 2025, with revenue increasing to $1,018.28 million, up from $879.097 million in the prior year, representing a 15.8% growth. The company swung from a net loss of $19.671 million in the nine months ended Septe
Sentiment Summary
Across 26 filings, the sentiment breakdown is: 2 bullish, 24 neutral. The dominant filing sentiment for Penumbra Inc is neutral.
Filing Type Overview
Penumbra Inc (PEN) has filed 2 425, 8 8-K, 5 10-Q, 2 DEF 14A, 2 10-K, 6 SC 13G/A, 1 SC 13G with the SEC between Jan 2024 to May 2026.
Filings by Year
Recent SEC Filings (26)
Risk Profile
Risk Assessment: Of PEN's 17 recent filings, 0 were flagged as high-risk, 4 as medium-risk, and 13 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $1,018.28M |
| Net Income | $130.344M |
| EPS | $3.32 |
| Cash Position | $321.029M |
| Operating Margin | 12.77% |
| Total Assets | $1,744.369M |
Key Executives
- Chief Executive Officer
- Dr. Aris T. Papageorge
- Abigail P. Johnson
Industry Context
Penumbra operates in the highly innovative and competitive medical device sector, specifically focusing on neuro and vascular interventions. Key trends include the increasing demand for minimally invasive procedures, advancements in AI-driven surgical tools, and a growing focus on treating complex conditions like ischemic stroke and venous thromboembolism. The market is characterized by significant R&D investment and a rigorous regulatory environment.
Top Tags
Medical Devices (4) · filing (3) · medical-devices (3) · 10-Q (3) · financials (3) · institutional-ownership (3) · amendment (3) · Revenue Growth (2) · governance (2) · 10-K (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Revenue | $1.018B | Increased by 15.8% from $879.097M in 2024 to $1.018B in 2025 for the nine-month period. |
| Net Income | $130.344M | Swung from a net loss of $19.671M in 2024 to a net income of $130.344M in 2025 for the nine-month period. |
| Impairment Charge | $76.945M | Absence of this charge in 2025 significantly contributed to net income improvement compared to 2024. |
| Net Cash Provided by Operating Activities | $152.179M | Increased from $117.373M in 2024 to $152.179M in 2025 for the nine-month period. |
| Purchases of Marketable Investments | $146.648M | Significant investing activity contributing to the decrease in cash and cash equivalents. |
| Q2 2025 Revenue | $322.0M | Increased from $280.0M in Q2 2024, a 15% growth. |
| Q2 2025 Net Income | $36.7M | Increased from $28.0M in Q2 2024, a 31% growth. |
| Revenue Growth | 15% | Percentage increase in revenue from Q2 2024 to Q2 2025. |
| Net Income Growth | 31% | Percentage increase in net income from Q2 2024 to Q2 2025. |
| Common Stock (June 30, 2025) | $0.322M | Reflects an increase from $0.280M at December 31, 2024. |
| Additional Paid-In Capital (June 30, 2025) | $1.367B | Indicates strong equity base for future investments. |
| Filing Date | 20250416 | Date the proxy statement was filed with the SEC. |
| Period of Report | 20250528 | The period the proxy statement pertains to. |
| Fiscal Year End | 1231 | Indicates the end of the company's fiscal year. |
| Fiscal Year | 2024 | Reporting period for the 10-K |
Forward-Looking Statements
- {"claim":"FMR LLC will maintain its significant passive stake in Penumbra Inc. for the foreseeable future.","entity":"FMR LLC","targetDate":"2025-02-09","confidence":"high"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Penumbra Inc (PEN)?
Penumbra Inc has 26 recent SEC filings from Jan 2024 to May 2026, including 8 8-K, 6 SC 13G/A, 5 10-Q. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of PEN filings?
Across 26 filings, the sentiment breakdown is: 2 bullish, 24 neutral. The dominant sentiment is neutral.
Where can I find Penumbra Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Penumbra Inc (PEN) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Penumbra Inc?
Key financial highlights from Penumbra Inc's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for PEN?
The investment thesis for PEN includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Penumbra Inc?
Key executives identified across Penumbra Inc's filings include Chief Executive Officer, Dr. Aris T. Papageorge, Abigail P. Johnson.
What are the main risk factors for Penumbra Inc stock?
Of PEN's 17 assessed filings, 0 were flagged high-risk, 4 medium-risk, and 13 low-risk.
What are recent predictions and forward guidance from Penumbra Inc?
Recent forward-looking statements from Penumbra Inc include guidance on {"claim":"FMR LLC will maintain its significant passive stake in Penumbra Inc. for the foreseeable future.","entity":"FM.